Efficacy and Safety Trends with Continuous Longterm Use of Crisaborole Ointment 2% in Patients with Mild-to-Moderate Atopic Dermatitis Research Developments in Atopic Dermatitis
-
- Medicine
The poster was presented by Dr. Lebwohl and colleagues at the 2020 American Academy of Dermatology virtual annual meeting.
This audio commentary is provided by Dr. Steve Feldman.
The poster was presented by Dr. Lebwohl and colleagues at the 2020 American Academy of Dermatology virtual annual meeting.
This audio commentary is provided by Dr. Steve Feldman.
6 min